MUC1 (CA27.29) before and after Chemotherapy and Prognosis in High-Risk Early Breast Cancer Patients

SIMPLE SUMMARY: CA27.29 (MUC1) is a well described biomarker for prediction of prognosis and treatment efficacy. CA27.29 is mainly evaluated in the preoperative setting. However, testing of postoperative levels and additional assessment after chemotherapy might be more informative for analyzing the...

Descripción completa

Detalles Bibliográficos
Autores principales: Huebner, Hanna, Häberle, Lothar, Müller, Volkmar, Schrader, Iris, Lorenz, Ralf, Forstbauer, Helmut, Fink, Visnja, Schochter, Fabienne, Bekes, Inga, Mahner, Sven, Jückstock, Julia, Nabieva, Naiba, Schneeweiss, Andreas, Tesch, Hans, Brucker, Sara Y., Blohmer, Jens-Uwe, Fehm, Tanja N., Heinrich, Georg, Rezai, Mahdi, Beckmann, Matthias W., Fasching, Peter A., Janni, Wolfgang, Rack, Brigitte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997086/
https://www.ncbi.nlm.nih.gov/pubmed/35406491
http://dx.doi.org/10.3390/cancers14071721

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997086/
https://www.ncbi.nlm.nih.gov/pubmed/35406491
http://dx.doi.org/10.3390/cancers14071721

Ejemplares similares